Xeljanz XR Coupon & Prices

Your monthly Xeljanz XR cost savings if eligible

If you are eligible for the Xeljanz XR patient assistance program, the cost of your medication will be free. We only charge $49 per month for each medication, to cover our service fees. You could receive your Xeljanz XR prescription for just $49 a month, regardless of the retail price of your medication.

Am I eligible for the Xeljanz XR patient assistance program?

We will review your application to determine whether you are eligible for the Xeljanz XR patient assistance program. Each program has its own eligibility criteria which is set by the pharmaceutical companies, however the factors considered by most programs are:

• I am a permanent, legal resident of the United States or Puerto Rico
• I am uninsured or my insurance doesn’t cover my medication
• I meet certain income eligibility requirements

How do I apply for the Xeljanz XR patient assistance program?

We make it as easy as possible to apply for the Xeljanz XR patient assistance program. The first step is to complete our enrollment application. Tell us about any medications you are taking, including Xeljanz XR. We will also ask for details about your healthcare provider, insurance, and your household income. This information is required by the pharmaceutical manufacturers who ship your medication.

If we determine that you may be eligible for Xeljanz XR assistance, we will handle the application process for you. We will work directly with your healthcare provider to prepare your application documents. Once we have received the signed application and supporting documents, we will submit them to the patient assistance program on your behalf. Our service continues once you are enrolled in the Xeljanz XR patient assistance program, and we will automatically request your Xeljanz XR medication refills for up to 1 year.

Is NiceRx a Xeljanz XR coupons provider?

We are a service provider that helps eligible individuals access the Xeljanz XR patient assistance program. That means that we do not offer printable Xeljanz XR manufacturer coupons, Xeljanz XR discounts, or free Xeljanz XR samples. We are not a Xeljanz XR coupon provider or Xeljanz XR discount card. Our service extends to assisting eligible individuals to access the medications they need through patient assistance programs.

Can NiceRx help me get Xeljanz XR if I have insurance?

We may be able to help you to access Xeljanz XR patient assistance in a variety of circumstances. This includes when your insurance company will not pay for your Xeljanz XR medication or if you have a high copay or coinsurance responsibility. We may also be able to help you if you do not have insurance. Please apply online to find out more.

How much does Xeljanz XR cost without insurance?

Xeljanz XR cost without insurance will vary depending on where you buy it. As a guide, Xeljanz XR oral tablet, extended-release 11 mg usually costs $5,450 for 30 tablets. With NiceRx you will pay a flat monthly fee of $49, regardless of the retail price of your medication.

How much does Xeljanz XR cost with insurance?

The copay for Xeljanz XR with insurance depends on the terms of your healthcare plan. To find out how much this is, your healthcare provider or pharmacist will be able to calculate your copay with your current insurance.

What is Xeljanz XR?

Xeljanz XR is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Pfizer Inc. Tofacitinib is a Janus kinase inhibitor (JAK inhibitor) used to treat certain types of arthritis such as psoriatic arthritis (PsA), rheumatoid arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis-pcJIA) in adults and pediatric patients who are two years of age and older who have had an inadequate response or intolerance to one or more TNF blockers.

Xeljanz is used:

• For the treatment of adult patients with moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs). The use of Xeljanz/Xeljanz XR in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended
• For the treatment of adult patients with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs). The use of Xeljanz/Xeljanz XR in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended
• For the treatment of adult patients with moderate to severe active ulcerative colitis (UC). The use of Xeljanz in combination with biological therapies for UC or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended

What doses of Xeljanz XR are available?

Xeljanz XR is available in the following formulations:

• Xeljanz tablets: 5 mg, 10 mg
• Xeljanz XR, extended-release tablets: 11 mg, 22 mg tofacitinib
• Xeljanz oral solution: 1 mg/mL

Please see the full prescribing information and medication guide for the complete boxed warning. Always speak with a healthcare professional for medical advice or about any changes to your dose so they can monitor and evaluate your condition.

Xeljanz XR active ingredients

Xeljanz XR contains tofacitinib as the active ingredient.

Xeljanz XR side effects

The most common side effects of Xeljanz XR in clinical trials compared to placebo include:

• Skin rash, shingles (herpes zoster)
• Increased blood pressure
• Fever, headache
• Nausea, vomiting, diarrhea
• Cold-like symptoms
• Upper respiratory tract infection, nasopharyngitis
• Elevated cholesterol levels
• Increased blood creatine phosphokinase

In rare instances, Xeljanz XR can cause more serious side effects. These can include:

• Serious infections – Xeljanz can lower the ability of your immune system to fight infections, leading to hospitalization or death, including tuberculosis and bacterial, invasive fungal, viral, and other opportunistic infections
• Lymphoma and other malignancies. Epstein Barr Virus-associated post-transplant lymphoproliferative disorder has been observed at an increased rate in renal transplant patients treated with Xeljanz and concomitant immunosuppressive medications
• Gastrointestinal perforations – use with caution in patients that may be at increased risk
• Potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes, and lipids
• Thrombosis, including pulmonary embolism, deep venous thrombosis, and arterial thrombosis

Your doctor will assess the benefits of using Xeljanz XR against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Xeljanz XR to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Xeljanz XR drug interactions

Xeljanz XR can interact with other medications. These include:

• Strong CP3A4 inhibitors (ketoconazole)
• Moderate CYP3A4 inhibitors coadministered with strong CYP2C19 inhibitors (fluconazole)
• Strong CYP3A4 inducers (rifampin)
• Immunosuppressive drugs (azathioprine, tacrolimus, cyclosporine)
• Live vaccines

This list is not exhaustive and other prescription drugs may interact with Xeljanz XR.

Xeljanz XR contraindications

You should not use Xeljanz XR if you:

• Are allergic to the active ingredient tofacitinib
• Have had an allergic reaction to any of the other ingredients in Xeljanz XR
• Are pregnant or are planning to become pregnant

Talk to your doctor before using Xeljanz XR if you:

• Are taking any of the medications that could interact with Xeljanz XR
• Have a weak immune system or chronic infection
• Have any type of cancer
• Have kidney disease, have had a kidney transplant, or if you are on dialysis
• Have diverticulitis, or an ulcer in your stomach or intestines
• Have any heart problems
• Have had a heart attack, stroke, or blood clot
• Have high cholesterol
• Have ever smoked – higher risk factor of certain cancers, including lymphoma and lung cancer, especially if you are a current or past smoker
• Have liver (especially hepatitis B or C)
• Have chronic lung disease
• Have diabetes
• Are breastfeeding or are planning to breastfeed – do not start breastfeeding again until 18 hours after your last dose of Xeljanz or 36 hours after your last dose of Xeljanz XR

Xeljanz XR generic

Xeljanz XR is the trademark brand name for tofacitinib manufactured by Pfizer Inc. A generic version of tofacitinib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Xeljanz XR savings through NiceRx.